Physician profile
Robert E Jeffries
NPI 1740275775
$2,510.70
in general payments reported to CMS, 2019-2025
19 companies · $381 in 2025
The $381 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $585 · 2020: $19.40 · 2021: $52.07 · 2022: $154 · 2023: $305 · 2024: $1,014 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,700.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,700.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $783.56 | 2024 | Optilight |
| Bausch & Lomb Americas INC. | $494.16 | 2022-2025 | Envista Mx60 Iol, Envista Envy Iol, Envista Aspire Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $224.26 | 2019 | |
| Alcon Vision LLC | $219.04 | 2019-2025 | Clareon Panoptix Pro, Clareon |
| Carl Zeiss Meditec, INC. | $132.25 | 2019 | |
| Biotissue Holdings INC. | $117.34 | 2025 | |
| Ocular Therapeutix, INC. | $117.28 | 2024 | Dextenza |
| Glaukos Corporation | $85.58 | 2019-2025 | Istent Infinite, Idosetr |
| Regeneron Pharmaceuticals, INC. | $71.24 | 2023 | Eylea Hd |
| Lensar, INC. | $45.05 | 2023 | Lensar Laser System |
| Rxsight INC | $43.20 | 2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Johnson & Johnson Surgical Vision, INC. | $32.09 | 2019-2023 | Tecnis Iol |
| Allergan, INC. | $28.59 | 2019-2021 | |
| New World Medical,INC. | $26.50 | 2023 | |
| Harrow Eye, LLC | $24.02 | 2025 | Triesence |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Eyevance Pharmaceuticals LLC | $18.83 | 2019 | |
| Abbvie INC. | $14.92 | 2022 | |
| Sun Pharmaceutical Industries INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Jeffries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.